CDKN2B-AS1 and atherosclerosis: According to Jarinova et al. and Congrains et al., the genetic variants of ANRIL influence atherosclerosis mechanisms such as thrombogenesis, vascular repair, and plaque stability by altering ANRIL expression and cell proliferation [32,33].